Literature DB >> 12646549

Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin.

B P Smyth1, J J O'Connor, J Barry, E Keenan.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12646549      PMCID： PMC1732426          DOI： 10.1136/jech.57.4.310

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN： 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  18 in total

1.  Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population.

Authors:  Elizabeth R Stevens; Kimberly A Nucifora; Holly Hagan; Ashly E Jordan; Jennifer Uyei; Bilal Khan; Kirk Dombrowski; Don des Jarlais; R Scott Braithwaite
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

2.  Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.

Authors:  L Grogan; M Tiernan; N Geogeghan; B Smyth; E Keenan
Journal:  Ir J Med Sci       Date:  2005 Apr-Jun       Impact factor: 1.568

Review 3.  A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

4.  Prisoners are at risk for hepatitis C transmission.

Authors:  Tony Butler; Azar Kariminia; Michael Levy; John Kaldor
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs.

Authors:  Yu Zhou; Li Sun; Xu Wang; Li Zhou; Jieliang Li; Manqing Liu; Fang Wang; Jinsong Peng; Xi'en Gui; Huaqing Zhao; Nancy Reichenbach; Dunjin Zhou; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-09       Impact factor: 4.147

6.  Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.

Authors:  Charlotte H S B van den Berg; Colette Smit; Margreet Bakker; Ronald B Geskus; Ben Berkhout; Suzanne Jurriaans; Roel A Coutinho; Katja C Wolthers; Maria Prins
Journal:  Eur J Epidemiol       Date:  2007-03-03       Impact factor: 8.082

7.  Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais; Corina Lelutiu-Weinberger
Journal:  Am J Epidemiol       Date:  2008-10-09       Impact factor: 4.897

8.  Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey.

Authors:  K J Cullen; V D Hope; S Croxford; J Shute; F Ncube; J V Parry
Journal:  Epidemiol Infect       Date:  2014-08-14       Impact factor: 4.434

9.  Chronic illness and multimorbidity among problem drug users: a comparative cross sectional pilot study in primary care.

Authors:  Walter Cullen; Sarah O'Brien; Austin O'Carroll; Fergus D O'Kelly; Gerard Bury
Journal:  BMC Fam Pract       Date:  2009-04-21       Impact factor: 2.497

Review 10.  Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.

Authors:  Georgie J MacArthur; Silvia Minozzi; Natasha Martin; Peter Vickerman; Sherry Deren; Julie Bruneau; Louisa Degenhardt; Matthew Hickman
Journal:  BMJ       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.